Dr Reddys Laboratories Ltd (RDY) — 20-F Filings
All 20-F filings from Dr Reddys Laboratories Ltd. Browse 1 Foreign Annual Report reports with AI-powered summaries and risk analysis.
20-F Filings (1)
-
Dr. Reddy's Faces Impairment Hits, Restructures Segments
— Jun 6, 2025 Risk: high
DR REDDYS LABORATORIES LTD reported inter-segment revenues from the PSAI segment to the Global Generics segment of Rs.9,389 for the year ended March 31, 2025, a
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX